Radiopharmaceutical Therapy
This book covers foundational topics in the emerging field of radiopharmaceutical therapy. It is divided into three sections: fundamentals, deeper dives, and special topics. In the first section, the authors examine the field from a bird’s-eye view, covering topics including the history of radiophar...
Guardado en:
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Lenguaje: | inglés |
| Publicado: |
Cham :
Springer International Publishing : Imprint: Springer,
2023.
|
| Edición: | 1st ed. 2023. |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-3-031-39005-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Tabla de Contenidos:
- Preface
- Foreword
- Section 1. Fundamentals
- Chapter 1. Introduction: The Case for Endoradiotherapy
- Chapter 2. The History of Endoradiotherapy
- Chapter 3. The Nuclear Chemistry of Therapeutic Radionuclides
- Chapter 4. The Production of Therapeutic Radionuclides
- Chapter 5. The Radiobiology of Alpha Particles, Beta Particles, and Auger Electrons
- Chapter 6. The Radiopharmaceutical Chemistry of Metallic Radionuclides
- Chapter 7. The Radiopharmaceutical Chemistry of Non-Metallic Radionuclides
- Chapter 8. Dosimetry in Endoradiotherapy
- Section 2. Deeper Dives
- Chapter 9. Antibodies as Vectors for Endoradiotherapy
- Chapter 10. Case Study #1: 225Ac-Labeled IgG
- Chapter 11. Case Study #2: 131I-3F8
- Chapter 12. Case Study #3: Antibody Fragments in Endoradiotherapy
- Chapter 13. Peptides as Vectors for Endoradiotherapy
- Chapter 14. Case Study #4: LUTATHERA
- Chapter 15. Case Study #5: CXCR4
- Chapter 16. Case Study #6: JR11
- Chapter 17. Small Molecules as Vectors for Endoradiotherapy
- Chapter 18. Case Study #7: PSMA-617
- Chapter 19. Case Study #8: 223RaCl3
- Section 3. Special Topics
- Chapter 20. Auger Emitters in Endoradiotherapy
- Chapter 21. In Vivo Pretargeting
- Chapter 22. Theranostic Imaging and Endoradiotherapy
- Chapter 23. The Next Generation of Therapeutic Radionuclides
- Chapter 24. Artificial Intelligence and Machine Learning
- Chapter 25. The Regulatory Review of Radiotherapeutics: USA
- Chapter 26. The Regulatory Review of Radiotherapeutics: Europe
- Chapter 27. The Regulatory Review of Radiotherapeutics: Japan
- Chapter 28. Radiotherapeutics in the Nuclear Pharmacy
- Chapter 29. The Future.